vs
Side-by-side financial comparison of loanDepot, Inc. (LDI) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.
loanDepot, Inc. is the larger business by last-quarter revenue ($310.3M vs $164.7M, roughly 1.9× PTC THERAPEUTICS, INC.). loanDepot, Inc. runs the higher net margin — -7.2% vs -82.0%, a 74.7% gap on every dollar of revenue. On growth, loanDepot, Inc. posted the faster year-over-year revenue change (20.5% vs -22.7%). PTC THERAPEUTICS, INC. produced more free cash flow last quarter ($-36.6M vs $-648.0M). Over the past eight quarters, loanDepot, Inc.'s revenue compounded faster (18.0% CAGR vs -11.5%).
LoanDepot, sometimes stylized as loanDepot, is an Irvine, California-based nonbank holding company which sells mortgage and non-mortgage lending products.
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
LDI vs PTCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $310.3M | $164.7M |
| Net Profit | $-22.5M | $-135.0M |
| Gross Margin | — | — |
| Operating Margin | -10.3% | -43.3% |
| Net Margin | -7.2% | -82.0% |
| Revenue YoY | 20.5% | -22.7% |
| Net Profit YoY | 32.4% | -104.8% |
| EPS (diluted) | — | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $310.3M | $164.7M | ||
| Q3 25 | $323.3M | $211.0M | ||
| Q2 25 | $282.5M | $178.9M | ||
| Q1 25 | $273.6M | $1.2B | ||
| Q4 24 | $257.5M | $213.2M | ||
| Q3 24 | $314.6M | $196.8M | ||
| Q2 24 | $265.4M | $186.7M | ||
| Q1 24 | $222.8M | $210.1M |
| Q4 25 | $-22.5M | $-135.0M | ||
| Q3 25 | $-4.9M | $15.9M | ||
| Q2 25 | $-13.4M | $-64.8M | ||
| Q1 25 | $-21.9M | $866.6M | ||
| Q4 24 | $-33.2M | $-65.9M | ||
| Q3 24 | $1.4M | $-106.7M | ||
| Q2 24 | $-32.2M | $-99.2M | ||
| Q1 24 | $-34.3M | $-91.6M |
| Q4 25 | -10.3% | -43.3% | ||
| Q3 25 | -3.2% | 1.4% | ||
| Q2 25 | -11.4% | -19.5% | ||
| Q1 25 | -16.8% | 82.5% | ||
| Q4 24 | -32.7% | -76.2% | ||
| Q3 24 | 1.1% | -27.7% | ||
| Q2 24 | -29.1% | -21.5% | ||
| Q1 24 | -38.2% | -21.6% |
| Q4 25 | -7.2% | -82.0% | ||
| Q3 25 | -1.5% | 7.5% | ||
| Q2 25 | -4.7% | -36.3% | ||
| Q1 25 | -8.0% | 73.7% | ||
| Q4 24 | -12.9% | -30.9% | ||
| Q3 24 | 0.4% | -54.2% | ||
| Q2 24 | -12.1% | -53.1% | ||
| Q1 24 | -15.4% | -43.6% |
| Q4 25 | — | $-1.63 | ||
| Q3 25 | — | $0.20 | ||
| Q2 25 | — | $-0.83 | ||
| Q1 25 | — | $10.04 | ||
| Q4 24 | — | $-0.85 | ||
| Q3 24 | $0.01 | $-1.39 | ||
| Q2 24 | $-0.18 | $-1.29 | ||
| Q1 24 | $-0.19 | $-1.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $337.2M | $1.9B |
| Total DebtLower is stronger | $2.1B | — |
| Stockholders' EquityBook value | $386.0M | $-205.3M |
| Total Assets | $6.9B | $2.9B |
| Debt / EquityLower = less leverage | 5.44× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $337.2M | $1.9B | ||
| Q3 25 | $459.2M | $1.7B | ||
| Q2 25 | $408.6M | $2.0B | ||
| Q1 25 | $371.5M | $2.0B | ||
| Q4 24 | $421.6M | $1.1B | ||
| Q3 24 | $483.0M | $1.0B | ||
| Q2 24 | $533.2M | $1.1B | ||
| Q1 24 | $603.7M | $884.8M |
| Q4 25 | $2.1B | — | ||
| Q3 25 | $2.1B | — | ||
| Q2 25 | $2.1B | — | ||
| Q1 25 | $2.0B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $2.0B | — | ||
| Q2 24 | $2.0B | — | ||
| Q1 24 | $2.3B | — |
| Q4 25 | $386.0M | $-205.3M | ||
| Q3 25 | $433.3M | $-155.8M | ||
| Q2 25 | $439.1M | $-206.5M | ||
| Q1 25 | $469.3M | $-185.8M | ||
| Q4 24 | $506.6M | $-1.1B | ||
| Q3 24 | $592.0M | $-1.1B | ||
| Q2 24 | $578.9M | $-980.2M | ||
| Q1 24 | $637.3M | $-893.9M |
| Q4 25 | $6.9B | $2.9B | ||
| Q3 25 | $6.2B | $2.6B | ||
| Q2 25 | $6.2B | $2.6B | ||
| Q1 25 | $6.4B | $2.7B | ||
| Q4 24 | $6.3B | $1.7B | ||
| Q3 24 | $6.4B | $1.8B | ||
| Q2 24 | $5.9B | $1.9B | ||
| Q1 24 | $6.2B | $1.8B |
| Q4 25 | 5.44× | — | ||
| Q3 25 | 4.83× | — | ||
| Q2 25 | 4.70× | — | ||
| Q1 25 | 4.30× | — | ||
| Q4 24 | 4.00× | — | ||
| Q3 24 | 3.31× | — | ||
| Q2 24 | 3.41× | — | ||
| Q1 24 | 3.63× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-638.7M | $-34.3M |
| Free Cash FlowOCF − Capex | $-648.0M | $-36.6M |
| FCF MarginFCF / Revenue | -208.9% | -22.3% |
| Capex IntensityCapex / Revenue | 3.0% | 1.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-734.6M | $702.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-638.7M | $-34.3M | ||
| Q3 25 | $43.4M | $-66.3M | ||
| Q2 25 | $67.6M | $-58.3M | ||
| Q1 25 | $-179.9M | $870.1M | ||
| Q4 24 | $47.7M | $-30.0M | ||
| Q3 24 | $-349.2M | $-77.0M | ||
| Q2 24 | $-278.3M | $-71.5M | ||
| Q1 24 | $-278.5M | $70.8M |
| Q4 25 | $-648.0M | $-36.6M | ||
| Q3 25 | $38.7M | $-69.7M | ||
| Q2 25 | $61.4M | $-59.6M | ||
| Q1 25 | $-186.7M | $868.4M | ||
| Q4 24 | $40.8M | $-33.8M | ||
| Q3 24 | $-356.4M | $-77.5M | ||
| Q2 24 | $-285.7M | $-78.8M | ||
| Q1 24 | $-283.3M | $61.2M |
| Q4 25 | -208.9% | -22.3% | ||
| Q3 25 | 12.0% | -33.1% | ||
| Q2 25 | 21.7% | -33.3% | ||
| Q1 25 | -68.2% | 73.8% | ||
| Q4 24 | 15.8% | -15.8% | ||
| Q3 24 | -113.3% | -39.4% | ||
| Q2 24 | -107.7% | -42.2% | ||
| Q1 24 | -127.2% | 29.1% |
| Q4 25 | 3.0% | 1.4% | ||
| Q3 25 | 1.5% | 1.6% | ||
| Q2 25 | 2.2% | 0.7% | ||
| Q1 25 | 2.5% | 0.1% | ||
| Q4 24 | 2.7% | 1.8% | ||
| Q3 24 | 2.3% | 0.3% | ||
| Q2 24 | 2.8% | 4.0% | ||
| Q1 24 | 2.1% | 4.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | -4.17× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.00× | ||
| Q4 24 | — | — | ||
| Q3 24 | -255.05× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
